ROL vs AMGN vs GILD vs SCI

For growth investors, Rollins, Inc.

(ROL) is the stronger pick with 11. 0% revenue growth year-over-year, versus 2. 4% for Gilead Sciences, Inc. (GILD). Gilead Sciences, Inc. (GILD) offers the better valuation at 19. 8x trailing P/E (15. 7x forward), making it the more compelling value choice. Analysts rate Amgen Inc. (AMGN) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Gilead Sciences, Inc.

(GILD) is the cheapest at 19. 8x versus Rollins, Inc. at 49. 9x. On forward P/E, Amgen Inc. is actually cheaper at 14. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Rollins, Inc. wins at 2. 96x versus Amgen Inc. 's 5. 01x.

Over the past 5 years, Gilead Sciences, Inc.

(GILD) delivered a total return of +124. 2%, compared to +46. 2% for Amgen Inc. (AMGN). Over 10 years, the gap is even starker: ROL returned +382. 5% versus GILD's +87. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Service Corporation International (SCI) is the lower-risk stock at 0.

11β versus Gilead Sciences, Inc. 's 0. 66β — meaning GILD is approximately 477% more volatile than SCI relative to the S&P 500. On balance sheet safety, Rollins, Inc. (ROL) carries a lower debt/equity ratio of 97% versus 6% for Amgen Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Rollins, Inc.

(ROL) is pulling ahead at 11. 0% versus 2. 4% for Gilead Sciences, Inc. (GILD). On earnings-per-share growth, the picture is similar: Gilead Sciences, Inc. grew EPS 1684% year-over-year, compared to 7. 6% for Service Corporation International. Over a 3-year CAGR, AMGN leads at 11. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Gilead Sciences, Inc.

(GILD) is the more profitable company, earning 28. 9% net margin versus 12. 6% for Service Corporation International — meaning it keeps 28. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GILD leads at 40. 1% versus 19. 4% for ROL. At the gross margin level — before operating expenses — GILD leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Rollins, Inc. (ROL) is the more undervalued stock at a PEG of 2. 96x versus Amgen Inc. 's 5. 01x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Amgen Inc. (AMGN) trades at 14. 7x forward P/E versus 44. 7x for Rollins, Inc. — 29. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GILD: 20. 8% to $161. 88.

All stocks in this comparison pay dividends.

Amgen Inc. (AMGN) offers the highest yield at 2. 9%, versus 1. 2% for Rollins, Inc. (ROL).

For long-horizon retirement investors, Service Corporation International (SCI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

11), 1. 6% yield, +225. 6% 10Y return). Both have compounded well over 10 years (SCI: +225. 6%, GILD: +87. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ROL (Consumer Cyclical) and AMGN (Healthcare) and GILD (Healthcare) and SCI (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.